Table 1.

Patients´ characteristics.

No.	Sex	Age	Myeloma type	Disease duration (months)	M gradient (g/l)	FLC (mg/l)	cytogenetics	Previous auto-SCT
1	m	69	IgG λ	26	27.75	287.0 (λ)	other	yes
2	m	61	IgG κ	16	6.41	47.8 (κ)	other	yes
3	m	50	light chain λ	37	0	1880.0 (λ)	other	yes
4	m	56	IgA κ	27	28.24	7.0 (κ)	other	yes
5	f	60	IgG κ	120	14.07	390.0 (κ)	n/a	yes
6	m	78	light chain κ	91	0	469.6 (κ)	n/a	no
7	m	72	IgG κ	11	0	18556.0 (κ)	n/a	no
8	f	64	IgG κ	128	52.65	1426.9 (κ)	other	yes
9	f	69	IgG κ	37	44.46	263.5 (κ)	high-risk	no
10	m	74	IgG κ	61	22.41	611.5 (κ)	n/a	yes
11	m	82	IgA κ	55	0	23.0 (κ)	other	no
12	f	64	IgG λ	85	0.97	0.4 (λ)	high-risk	yes
13	m	51	light chain λ	57	0	2644.0 (λ)	other	yes
14	m	66	light chain λ	33	0	5260.0 (λ)	other	no
15	m	65	IgG κ	160	0	4061.0 (κ)	other	yes
16	f	66	light chain κ	67	0	1349.0 (κ)	n/a	yes
17	m	53	IgG κ	47	6.16	74.5 (κ)	n/a	yes
18	f	58	light chain λ	57	0	102.7 (λ)	n/a	yes
19	m	65	light chain κ	106	0	14.7 (κ)	n/a	yes
20	m	66	IgG κ	22	1.,57	270.5 (κ)	n/a	yes
21	f	65	IgA κ	12	0	2387.0 (κ)	high-risk	yes
22	f	53	light chain κ	121	0	99.7 (κ)	other	yes
23	f	62	light chain κ	54	0	5243.0 (κ)	n/a	yes
24	f	57	IgG κ	61	26.97	752.4 (κ)	high-risk	yes
25	m	65	IgA κ	100	32.65	401.6 (κ)	high-risk	yes
26	f	58	IgA κ	59	36.87	1306.0 (κ)	n/a	yes
27	m	62	IgG λ	195	49.24	139.6 (λ)	other	yes
28	m	67	light chain λ	146	0	1165.9 (λ)	n/a	yes
29	m	67	IgG κ	38	33.02	5008.0 (κ)	high-risk	yes
30	m	44	asecetory	16	0	n/a	n/a	yes
31	f	58	light chain κ	12	0	37.6 (κ)	high-risk	0
32	m	73	IgA λ	113	13.19	4696.0	n/a	0
33	m	65	IgA λ	9	0	123.8	high-risk	yes
34	m	52	IgG κ	75	0	77.4 (κ)	high-risk	yes
35	m	48	IgG κ	17	n/a	n/a	high-risk	yes